Supplemental Adjuvants for Intracellular Nutrition and Treatment

• Status: Unknown status
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Nutritional supplements have an augmentative effect on the outcomes of standard treatment of diabetic macular edema (DME) and Neovascular Age-Related Macular Degeneration (NAMD).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mid-Atlantic Retina Consultations, Inc.
• Collaborator: West Virginia University
• Treatments: Acetylcysteine; alpha-Tocopherol; Ascorbic Acid; Coenzyme Q10; Minocycline; N-monoacetylcystine; Niacin; Niacinamide; Nicotinic Acids; Tocopherols; Tocotrienols; Ubiquinone; Vitamin E; Vitamins

Criteria

Inclusion Criteria:

• Clinical Diagnosis of NAMD

• Clinical Diagnosis of DME

Exclusion Criteria:

• Pregnant Women

• Known allergy to any component used in the treatment combinations